Preeclampsia, which manifests as severely elevated blood pressure during pregnancy and can be accompanied by other symptoms, has numerous risk factors in common with cardiovascular disease. In their research, Dr. Tanja Zeller's team from the UKE Hamburg evaluated the potential benefit of cardiac troponin I levels (hs-cTnI) during pregnancy for predicting the occurrence of pre-eclampsia. The study results show that hs-cTnI can be considered, alongside maternal factors, as a complementary biomarker in the prediction of the disease.
Link to the original publication: High-Sensitivity Cardiac Troponin I Enhances Preeclampsia Prediction Beyond Maternal Factors and the sFlt-1/PlGF Ratio